More Pharma Mergers Will Be Presumed Anticompetitive Under New FTC/DOJ Guidelines

 
• By Brenda Sandburg
M&A review
Revised draft merger guidelines make it easier for the government to claim deals are anticompetitive. • Source: Shutterstock

More from Compliance

More from Pink Sheet